Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: a post-hoc analysis of the AVERT trial - Ladha, D; Mallick, R; Wang, T F; Caiano, L; Wells, P S; Carrier, M (Thromb Res, 2021)